Kenshiro Shiraishi
Teikyo University Hospital, Teikyo University, University of Tokyo Hospital
Papers
3
Total Citations
16
H-Index
3
About
Kenshiro Shiraishi is a leading urologic oncologist whose research focuses on optimizing treatment strategies for localized prostate cancer. His work directly addresses one of the most critical debates in the field: comparing the long-term oncological outcomes of robot-assisted radical prostatectomy (RARP) versus modern external beam radiotherapy, specifically volumetric modulated arc therapy (VMAT). Dr. Shiraishi’s major contributions include providing some of the first direct, propensity score-matched comparisons between these two advanced techniques. His 2019 study, with 7 citations, established a foundational comparison of front-line therapies, while his 2020 work (6 citations) synthesized updated evidence on the surgery-versus-radiotherapy debate, highlighting the nuanced comparability and potential superiority of surgery. Most recently, his 2024 six-year outcomes analysis (3 citations) broke new ground by being among the first to compare mortality outcomes between RARP and VMAT. By rigorously controlling for patient variables, Dr. Shiraishi’s research provides clinicians with critical, evidence-based data to guide personalized treatment decisions, helping patients and doctors weigh the trade-offs between surgical and radiological approaches for localized prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3